Works matching IS 03407004 AND DT 2006 AND VI 55 AND IP 12
Results: 15
In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 12, p. 1480, doi. 10.1007/s00262-006-0142-x
- By:
- Publication type:
- Article
Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 12, p. 1491, doi. 10.1007/s00262-006-0138-6
- By:
- Publication type:
- Article
Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 12, p. 1553, doi. 10.1007/s00262-006-0145-7
- By:
- Publication type:
- Article
CD40 ligation restores cytolytic T lymphocyte response and eliminates fibrosarcoma in the peritoneum of mice lacking CD4<sup>+</sup> T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 12, p. 1542, doi. 10.1007/s00262-006-0147-5
- By:
- Publication type:
- Article
Increased liver temperature efficiently augments human cellular immune response: T-cell activation and possible monocyte translocation.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 12, p. 1459, doi. 10.1007/s00262-006-0146-6
- By:
- Publication type:
- Article
Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 12, p. 1451, doi. 10.1007/s00262-006-0148-4
- By:
- Publication type:
- Article
Macrophage inflammatory protein (MIP)1 α and MIP1 β differentially regulate release of inflammatory cytokines and generation of tumoricidal monocytes in malignancy.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 12, p. 1534, doi. 10.1007/s00262-006-0149-3
- By:
- Publication type:
- Article
Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 12, p. 1575, doi. 10.1007/s00262-006-0152-8
- By:
- Publication type:
- Article
Mechanism of action differences in the antitumor effects of transmembrane and secretory tumor necrosis factor-alpha in vitro and in vivo.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 12, p. 1470, doi. 10.1007/s00262-006-0150-x
- By:
- Publication type:
- Article
Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 12, p. 1565, doi. 10.1007/s00262-006-0155-5
- By:
- Publication type:
- Article
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 12, p. 1524, doi. 10.1007/s00262-006-0157-3
- By:
- Publication type:
- Article
A mechanistic study of immune system activation by fusion of antigens with the ligand-binding domain of CTLA4.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 12, p. 1504, doi. 10.1007/s00262-006-0153-7
- By:
- Publication type:
- Article
STEAP, a prostate tumor antigen, is a target of human CD8<sup>+</sup> T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 12, p. 1515, doi. 10.1007/s00262-006-0165-3
- By:
- Publication type:
- Article
Target-selective activation of a TNF prodrug by urokinase-type plasminogen activator (uPA) mediated proteolytic processing at the cell surface.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 12, p. 1590, doi. 10.1007/s00262-006-0162-6
- By:
- Publication type:
- Article
Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 12, p. 1584, doi. 10.1007/s00262-006-0167-1
- By:
- Publication type:
- Article